Faculty Opinions recommendation of Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1229980.697084 ◽

2009 ◽

Author(s):

Martin Aringer ◽

Alexander Kleymann

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effect of saffron supplement on clinical outcomes and metabolic profiles in patients with active rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled clinical trial

Phytotherapy Research ◽

10.1002/ptr.6633 ◽

2020 ◽

Vol 34 (7) ◽

pp. 1650-1658 ◽

Author(s):

Zahra Hamidi ◽

Naheed Aryaeian ◽

Jamileh Abolghasemi ◽

Fatemeh Shirani ◽

Mahsa Hadidi ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Clinical Outcomes ◽

Active Rheumatoid Arthritis ◽

Controlled Clinical Trial ◽

Metabolic Profiles ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial

Annals of the Rheumatic Diseases ◽

10.1136/ard.2011.151522 ◽

2011 ◽

Vol 70 (12) ◽

pp. 2119-2125 ◽

Author(s):

P. C. Taylor ◽

E. Quattrocchi ◽

S. Mallett ◽

R. Kurrasch ◽

J. Petersen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Monoclonal Antibody ◽

Controlled Clinical Trial ◽

Inadequate Response ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

Arthritis & Rheumatism ◽

10.1002/art.23417 ◽

2008 ◽

Vol 58 (5) ◽

pp. 1299-1309 ◽

Author(s):

Stanley B. Cohen ◽

Robin K. Dore ◽

Nancy E. Lane ◽

Peter A. Ory ◽

Charles G. Peterfy ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Bone Mineral Density ◽

Clinical Trial ◽

Bone Turnover ◽

Phase Ii ◽

Structural Damage ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Denosumab Treatment

Download Full-text

Denosumab Treatment Effects on Structural Damage, Bone Mineral Density, and Bone Turnover in Rheumatoid Arthritis: A Twelve-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial

Yearbook of Medicine ◽

10.1016/s0084-3873(09)79332-0 ◽

2009 ◽

Vol 2009 ◽

pp. 12-13

Author(s):

N. Cotter

Keyword(s):

Rheumatoid Arthritis ◽

Bone Mineral Density ◽

Clinical Trial ◽

Bone Turnover ◽

Phase Ii ◽

Structural Damage ◽

Mineral Density ◽

Double Blind ◽

Double Blind Placebo ◽

Denosumab Treatment

Download Full-text

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial

Rheumatology ◽

10.1093/rheumatology/kel066 ◽

2006 ◽

Vol 45 (10) ◽

pp. 1238-1246 ◽

Author(s):

R. Westhovens ◽

J. C. Cole ◽

T. Li ◽

M. Martin ◽

R. MacLean ◽

...

Keyword(s):

Quality Of Life ◽

Rheumatoid Arthritis ◽

Clinical Trial ◽

Inadequate Response ◽

Health Related Quality ◽

Double Blind ◽

Double Blind Placebo ◽

Related Quality ◽

Download Full-text

Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

Arthritis & Rheumatism ◽

10.1002/art.10294 ◽

2002 ◽

Vol 46 (6) ◽

pp. 1470-1479 ◽

Author(s):

Larry W. Moreland ◽

Rieke Alten ◽

Filip Van Den Bosch ◽

Thierry Appelboom ◽

Marc Leon ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Dose Finding ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Costimulatory Blockade

Download Full-text

Effects of coenzyme Q10 supplementation on matrix metalloproteinases and DAS-28 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial

Clinical Rheumatology ◽

10.1007/s10067-019-04723-x ◽

2019 ◽

Vol 38 (12) ◽

pp. 3367-3374 ◽

Author(s):

Seyed Mostafa Nachvak ◽

Beitollah Alipour ◽

Aida Malek Mahdavi ◽

Mir Amir Aghdashi ◽

Hadi Abdollahzad ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Matrix Metalloproteinases ◽

Coenzyme Q10 ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Das 28 ◽

Coenzyme Q10 Supplementation

Download Full-text

A randomized, double‐blind, placebo‐controlled clinical trial, evaluating the garlic supplement effects on some serum biomarkers of oxidative stress, and quality of life in women with rheumatoid arthritis

International Journal of Clinical Practice ◽

10.1111/ijcp.13498 ◽

2020 ◽

Vol 74 (7) ◽

Author(s):

Seyedeh Parisa Moosavian ◽

Zamzam Paknahad ◽

Zahra Habibagahi

Keyword(s):

Quality Of Life ◽

Rheumatoid Arthritis ◽

Oxidative Stress ◽

Clinical Trial ◽

Serum Biomarkers ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Biomarkers Of Oxidative Stress

Download Full-text

Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial

Annals of the Rheumatic Diseases ◽

10.1136/ard.2008.095539 ◽

2008 ◽

Vol 68 (11) ◽

pp. 1715-1720 ◽

Author(s):

T Pincus ◽

C J Swearingen ◽

G Luta ◽

T Sokka

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Annals of Internal Medicine ◽

10.7326/0003-4819-136-1-200201010-00006 ◽

2002 ◽

Vol 136 (1) ◽

pp. 1 ◽

Author(s):

Amalia A. van Everdingen ◽

Johannes W.G. Jacobs ◽

Dirk R. Siewertsz van Reesema ◽

Johannes W.J. Bijlsma

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Side Effects ◽

Active Rheumatoid Arthritis ◽

Low Dose ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Dose Prednisone

Download Full-text